Dr. Stefanie Davidson reviews the highlights from this year’s American Association for Pediatric Ophthalmology and Strabismus (AAPOS) meeting. CHOP Expert Commentary
Month: May 2014
EMA committee supports Simbrinza safety, efficacy for glaucoma
Alcon announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency supports the safety and efficacy of brinzolamide eye drops suspension for adult patients with open-angle glaucoma or ocular hypertension, according…
Viewpoints: It’s past time to move on VA’s problems; administration should report new health law numbers
When America sends men and women to fight, it owes them an enduring debt, starting with competent and timely health care and disability benefits when they leave active duty. President Obama expressed outrage on Wednesday at recent charges of wrongdoing…
CDVA lost in short-term, regained at 1 year after SMILE
Small-incision lenticule extraction showed an acceptable safety profile despite a relatively high percentage of eyes that lost corrected distance visual acuity at 3 months, according to a study.The clinical-control cohort study included 1,800 eyes of 9…
Novartis reports 2014 Q1 sales, profit growth
Novartis reported a 1% increase in net sales to $14 billion in the first quarter of 2014, according to a press release.“Novartis delivered a solid quarter, with all divisions contributing to growth. We made progress in innovation, including [European Union] and U.S. approval of Xolair in chronic spontaneous urticaria and significant milestones for Bexsero,” Joseph Jimenez, CEO of Novartis, said in the release.
Regeneron announces $626 million in 2014 first quarter revenue
Regeneron reported total revenue of $626 million in the first quarter of 2014, a 42% increase from its 2013 first quarter revenue of $440 million, according to a press release.Net product sales were reported at $362 million, increasing by $43 million f…
Surgical Innovations in Pediatric Ophthalmology
iTunes conversion to RSS provided by Feed Flipper: [Web] – [Facebook] – [Donate!]
Dr. Stefanie Davidson reviews the highlights from this year’s American Association for Pediatric Ophthalmology and Strabismus (AAPOS) meeting.
Doctors Are Talking: EHRs Destroy the Patient Encounter
Recent Medscape articles on EHRs have sparked heated debates, especially on how EHRs obstruct the doctor-patient relationship. See what your colleagues are saying, and weigh in with your own opinion. Medscape Business of Medicine
Needlestick risk linked to stickers on syringes from compounding pharmacies
Placement of adhesive stickers directly onto syringes at compounding pharmacies resulted in increased risk of needlestick injuries, according to a study.A nine-question online survey was sent to 717 retina specialists in the U.S.; 158 specialists (22%)…
Hydrophilic acrylic IOL shows high long-term safety profile for eyes with uveitis
A hydrophilic acrylic IOL improved vision and maintained a good long-term safety profile in eyes with uveitis, according to a study.The retrospective study included 171 eyes of 140 patients with uveitis who underwent phacoemulsification and implantatio…
IRIDEX’ Micropulse technology safe, durable for treating glaucoma
IRIDEX Corporation (Nasdaq: IRIX) today announced that data from a one-year, multi-center study demonstrates the safety and durability of its proprietary MicroPulse technology as a treatment for glaucoma.
Iridex reports 16% revenue increase in 2014
Iridex Corporation reported revenue of $10.3 million in the first quarter of 2014, up 16% from $8.9 million in the first quarter of 2013, according to a press release.The company also reported an increase in gross margin to 48.9%, up from 47.3% in the …
EHR Divide Is Widening Among Physicians, CDC Says
When it comes to EHR adoption, physicians in large practices are outpacing soloists. The gap between primary care physicians and specialists has grown as well. Medscape Medical News
Aerie reports financial results for first quarter of 2014
Aerie Pharmaceuticals reported first quarter earnings of $65.1 million in cash, cash equivalents and short-term investments, according to a press release.This revenue is expected to fund phase 3 development of Rhopressa, a once-daily eye drop targeting…
Ocular sarcoidosis an increased risk for male smokers
Cigarette smoking and male sex are significant risk factors for developing ocular sarcoidosis, according to a new study presented at the 2014 American Thoracic Society International Conference.
CMS Tightens Controls on Medicare Prescribing
Final ruling says all prescribers must be enrolled in Medicare in light of reports that show some drug orders are coming from unauthorized providers. Medscape Medical News
VisionWalk a Success | Foundation Fighting Blindness
As you remember, I became medical chair for FFB/VisionWalk, norther Virginia this year. The event was a huge success…and I want to repeat next year!
Akorn reports 23% revenue increase over last year
Akorn reported revenue of $90.6 million, a 23% increase from last year’s first quarter revenue of $73.9 million, according to a press release.The company also announced a record operating cash flow of $23.4 million for their first quarter results.
BLOG: Phacoemulsification; what to do when there is no view
Phacoemulsification in cases with media opacities and poor corneal clarity is a challenge that needs to be addressed adequately with surgical expertise and precision during the intraoperative procedure. Patients with Fuchs’ dystrophy and corneal guttat…
SEE Study: Dry eye has insignificant effect on reading speed among seniors
Dry eye did not significantly reduce reading speed but was associated with difficulty reading newsprint among seniors, according to a large study.“Given the importance of comfortable reading to real world functionality and quality of life, further study of how and why dry eye affects reading is merited,” the study authors said.